Lupase 25000 Tablet contains Pancreatin 300 mg, a combination of digestive enzymes including amylase, lipase, and protease, which aid in the breakdown of carbohydrates, fats, and proteins respectively. It is primarily indicated for patients with pancreatic exocrine insufficiency resulting from conditions such as chronic pancreatitis, cystic fibrosis, pancreatic surgery, or other disorders leading to inadequate pancreatic enzyme secretion. By supplementing endogenous enzymes, Lupase 25000 enhances nutrient digestion and absorption, thereby alleviating symptoms like steatorrhea, malnutrition, bloating, and abdominal discomfort. The tablet should be administered orally with meals or snacks to ensure optimal enzyme activity during digestion. Dosage must be individualized based on the severity of enzyme deficiency and clinical response, with careful titration to avoid adverse effects. Common side effects are generally mild and may include gastrointestinal disturbances such as nausea, abdominal pain, or diarrhea. Hypersensitivity reactions are rare but warrant immediate discontinuation and medical attention. Lupase 25000 is contraindicated in patients with known hypersensitivity to pancreatin or any component of the formulation. Caution is advised in patients with acute pancreatitis or pancreatic carcinoma. This medication should be used under medical supervision, with periodic assessment of therapeutic efficacy and nutritional status.